EP4720093A2 - Procédés de fabrication de conjugués peptidiques et produit fabriqué à partir de ceux-ci - Google Patents
Procédés de fabrication de conjugués peptidiques et produit fabriqué à partir de ceux-ciInfo
- Publication number
- EP4720093A2 EP4720093A2 EP24816508.6A EP24816508A EP4720093A2 EP 4720093 A2 EP4720093 A2 EP 4720093A2 EP 24816508 A EP24816508 A EP 24816508A EP 4720093 A2 EP4720093 A2 EP 4720093A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- peptide
- compound
- seq
- hrc
- linker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne un procédé de synthèse de conjugués peptidiques par chimie en flux automatisé, le procédé comprenant la synthèse d'une structure covalente se liant à différents modules, la structure covalente comprenant au moins un acide diaminoaliphatique, de préférence la lysine ; ainsi que le produit obtenu à partir de celui-ci, par exemple, des conjugués peptidiques antiviraux.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363470257P | 2023-06-01 | 2023-06-01 | |
| PCT/US2024/031869 WO2024249765A2 (fr) | 2023-06-01 | 2024-05-31 | Procédés de fabrication de conjugués peptidiques et produit fabriqué à partir de ceux-ci |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4720093A2 true EP4720093A2 (fr) | 2026-04-08 |
Family
ID=93658727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP24816508.6A Pending EP4720093A2 (fr) | 2023-06-01 | 2024-05-31 | Procédés de fabrication de conjugués peptidiques et produit fabriqué à partir de ceux-ci |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4720093A2 (fr) |
| CN (1) | CN121712791A (fr) |
| AU (1) | AU2024278914A1 (fr) |
| WO (1) | WO2024249765A2 (fr) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993022343A1 (fr) * | 1992-05-01 | 1993-11-11 | The Rockfeller University | Systeme antigenique a plusieurs peptides possedant des proprietes d'adjuvant, vaccins prepares a partir dudit systeme |
| WO2022159372A1 (fr) * | 2021-01-22 | 2022-07-28 | Decoy Therapeutics, Inc. | Procédés et compositions pour traiter des infections |
-
2024
- 2024-05-31 CN CN202480049857.4A patent/CN121712791A/zh active Pending
- 2024-05-31 EP EP24816508.6A patent/EP4720093A2/fr active Pending
- 2024-05-31 AU AU2024278914A patent/AU2024278914A1/en active Pending
- 2024-05-31 WO PCT/US2024/031869 patent/WO2024249765A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024249765A3 (fr) | 2025-03-13 |
| WO2024249765A2 (fr) | 2024-12-05 |
| AU2024278914A1 (en) | 2026-01-15 |
| CN121712791A (zh) | 2026-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Parray et al. | Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections | |
| ES3002666T3 (en) | Improved peptide pharmaceuticals for treatment of nash and other disorders | |
| US8299214B2 (en) | Influenza infection-inhibiting peptide, influenza virus infection inhibitor, liposome, and influenza preventive/therapeutic agent | |
| US20250387468A1 (en) | Methods and Compositions for Treating Infections | |
| ES3053993T3 (en) | Optimised compounds | |
| JP2026000993A (ja) | 新ペプチド | |
| CN103200955A (zh) | 包含肽和病毒神经氨酸酶抑制剂的组合物 | |
| CN120699110B (zh) | 一种抗rsv的多肽膜融合抑制剂及其制备方法和用途 | |
| EP4720093A2 (fr) | Procédés de fabrication de conjugués peptidiques et produit fabriqué à partir de ceux-ci | |
| US20240108735A1 (en) | Methods and compositions for treating covid infections | |
| JP2025505673A (ja) | Covid感染症を処置するための方法および組成物 | |
| ES2337663T3 (es) | Compuestos peptidicos que se unen selectivamente a p-selectina. | |
| AU2018284219A1 (en) | Hydrochloride salts of C5a receptor agonist peptides | |
| US20240366712A1 (en) | Griffithsin for use in a method of preventing or treating infections with respiratory viruses | |
| US20260077052A1 (en) | Methods For Reducing Or Preventing SARS-COV-2 Infection And Transmission | |
| JP2002012555A (ja) | インフルエンザ予防剤 | |
| AU2021278137A1 (en) | Pharmaceutical composition comprising polynucleotides and use thereof for prevention or treatment of COVID-19 | |
| WO2001080892A1 (fr) | Substances preventives de la grippe | |
| WO2025231182A9 (fr) | Nouvelle formulation de conjugués peptidiques antiviraux | |
| CN114989259A (zh) | 一种小分子肽Ped4及应用 | |
| HK40083799A (en) | Clofazimine composition and method for the treatment or prophylaxis of viral infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20251229 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |